NOVN.CH

97.19

+0.51%↑

SOON.CH

255.8

+1.07%↑

NOVN.CH

97.19

+0.51%↑

SOON.CH

255.8

+1.07%↑

NOVN.CH

97.19

+0.51%↑

SOON.CH

255.8

+1.07%↑

NOVN.CH

97.19

+0.51%↑

SOON.CH

255.8

+1.07%↑

NOVN.CH

97.19

+0.51%↑

SOON.CH

255.8

+1.07%↑

Search

Roche Holding AG

Fechado

SetorSaúde

286.8 0.14

Visão Geral

Variação de preço das ações

24h

Atual

Mín

286

Máximo

286.8

Indicadores-chave

By Trading Economics

Rendimento

-4.2B

2B

Vendas

-109M

31B

P/E

Médio do Setor

27.255

51.198

Rendimento de Dividendos

3.45

Margem de lucro

6.588

Funcionários

103,249

EBITDA

-4.6B

6B

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

3.45%

2.40%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-6.2B

213B

Abertura anterior

286.66

Fecho anterior

286.8

Sentimento de Notícias

By Acuity

32%

68%

87 / 380 Ranking em Healthcare

Roche Holding AG Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

12 de mai. de 2025, 02:16 UTC

Grandes Movimentos do Mercado

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

24 de abr. de 2025, 07:30 UTC

Ganhos

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24 de abr. de 2025, 05:31 UTC

Ganhos

Roche Sales Rise Boosted By Key Drugs

9 de abr. de 2025, 09:39 UTC

Grandes Movimentos do Mercado

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

12 de mar. de 2025, 09:23 UTC

Grandes Movimentos do Mercado

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

30 de jan. de 2025, 09:36 UTC

Ganhos

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

30 de jan. de 2025, 06:32 UTC

Ganhos

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

3 de jun. de 2025, 07:51 UTC

Conversa de Mercado

Roche Unlikely to Get Revenue Boost From Tecentriq Combination With Lurbinectedin -- Market Talk

21 de mai. de 2025, 07:20 UTC

Conversa de Mercado

Roche Lymphoma Drug Columvi Dealt Setback by FDA Committee -- Market Talk

2 de mai. de 2025, 06:25 UTC

Conversa de Mercado
Ganhos

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

24 de abr. de 2025, 09:39 UTC

Conversa de Mercado
Ganhos

Roche's Pipeline in Focus After Solid Results -- Market Talk

24 de abr. de 2025, 09:24 UTC

Conversa de Mercado
Ganhos

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24 de abr. de 2025, 09:18 UTC

Conversa de Mercado
Ganhos

Roche's Results Are Solid -- Market Talk

24 de abr. de 2025, 05:16 UTC

Principais Notícias

Roche Sales Rise, Boosted By Key Drugs

22 de abr. de 2025, 10:51 UTC

Principais Notícias

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15 de abr. de 2025, 09:55 UTC

Conversa de Mercado

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9 de abr. de 2025, 10:03 UTC

Conversa de Mercado
Ganhos

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

9 de abr. de 2025, 07:23 UTC

Conversa de Mercado

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3 de abr. de 2025, 08:41 UTC

Conversa de Mercado

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3 de abr. de 2025, 07:51 UTC

Conversa de Mercado

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

31 de mar. de 2025, 09:31 UTC

Ações em Alta

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

13 de mar. de 2025, 07:46 UTC

Conversa de Mercado

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

12 de mar. de 2025, 16:34 UTC

Principais Notícias

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

12 de mar. de 2025, 08:51 UTC

Conversa de Mercado

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

12 de mar. de 2025, 08:18 UTC

Conversa de Mercado

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

13 de fev. de 2025, 11:43 UTC

Conversa de Mercado

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

30 de jan. de 2025, 07:56 UTC

Conversa de Mercado
Ganhos

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

30 de jan. de 2025, 06:04 UTC

Ganhos

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

30 de jan. de 2025, 06:04 UTC

Ganhos

Roche Expects 2025 Sales Increase in Mid Single Digit Range at Constant Currency

30 de jan. de 2025, 06:04 UTC

Ganhos

Roche Issues 2025 View

Comparação entre Pares

Variação de preço

Roche Holding AG Previsão

Sentimento

By Acuity

87 / 380 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.